Check out the companies making headlines in midday trading: Bristol-Myers Squibb — The drug maker jumped 1.6% after the U.S. Food and Drug Administration approved a...
Year: 2024
Key Fed inflation gauge at 2.2% in August, lower than expected
Inflation moved closer to the Federal Reserve’s target in August, easing the way for future interest rate cuts, the Commerce Department reported Friday. The personal consumption...
We’re upping our price target on Costco after another steady quarter fortifies our thesis
Costco on Thursday reported ho-hum quarterly results, with a small topline miss being more than offset by strong profitability to deliver an earnings beat. The report...
FDA approves Bristol Myers Squibb’s schizophrenia drug, the first new type of treatment in decades
Bristol Myers Squibb’s Cobenfy drug Courtesy: Bristol Myers Squibb The Food and Drug Administration on Thursday approved Bristol Myers Squibb‘s highly anticipated schizophrenia drug Cobenfy, the...